May 19, 2021 .
The Center Will Collect Real-World Data on AMBAR® Clinical Program .
- AMBAR® Center combines Grifols' more than 15 years of knowledge researching this devastating disease with the experience of the non-profit medical foundation Ace Alzheimer Center Barcelona in diagnosing and treating Alzheimer's patients, including application of AMBAR® (Alzheimer Management by Albumin Replacement) .
- The AMBAR® clinical program, based on periodic plasma exchange with albumin, has shown a delay in the cognitive and functional progression of Alzheimer's disease in mild-to-moderate patients .
- Ace Alzheimer Center will manage the center, to be located on its premises in Barcelona. Grifols will partner with other leading medical institutions to open expected future centers in the EU, U.S. and China, obtaining AMBAR® data from clinical practice and advancing further in the therapeutic management of the disease
...